Search details
1.
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).
J Antimicrob Chemother
; 74(3): 739-745, 2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30476165
2.
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).
AIDS Behav
; 22(10): 3264-3272, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-29512033
3.
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
J Antimicrob Chemother
; 72(4): 1137-1146, 2017 04 01.
Article
in English
| MEDLINE | ID: mdl-28065890
4.
Abacavir has no prothrombotic effect on platelets in vitro.
J Antimicrob Chemother
; 71(12): 3506-3509, 2016 12.
Article
in English
| MEDLINE | ID: mdl-27516475
5.
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
J Antimicrob Chemother
; 71(2): 490-6, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26568566
6.
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.
J Lipid Res
; 56(3): 692-702, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25573889
7.
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
J Antimicrob Chemother
; 69(10): 2819-25, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24948705
8.
[HIV infection and social condition: a disease which remains singular]. / Infection par le VIH et société: une maladie qui demeure singulière.
Rev Prat
; 64(8): 1099-102, 2014 Oct.
Article
in French
| MEDLINE | ID: mdl-25510134
9.
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Antimicrob Agents Chemother
; 57(2): 758-65, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23165467
10.
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
J Antimicrob Chemother
; 68(3): 690-6, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23152480
11.
Antiretroviral treatments in 2012: improvements and future prospects.
Virologie (Montrouge)
; 17(3): 182-192, 2013 Jun 01.
Article
in English
| MEDLINE | ID: mdl-31910545
12.
Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
J Antimicrob Chemother
; 67(6): 1459-61, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22382470
13.
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
J Antimicrob Chemother
; 67(9): 2231-5, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22643190
14.
Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity.
J Virol
; 85(22): 11846-54, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21917976
15.
Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir.
Antimicrob Agents Chemother
; 55(4): 1754-7, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21282435
16.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
N Engl J Med
; 359(4): 339-54, 2008 Jul 24.
Article
in English
| MEDLINE | ID: mdl-18650512
17.
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
N Engl J Med
; 359(4): 355-65, 2008 Jul 24.
Article
in English
| MEDLINE | ID: mdl-18650513
18.
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).
J Antimicrob Chemother
; 66(1): 184-91, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-21036772
19.
[ 18 F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis.
Front Med (Lausanne)
; 8: 715115, 2021.
Article
in English
| MEDLINE | ID: mdl-34485345
20.
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
Clin Infect Dis
; 50(4): 605-12, 2010 Feb 15.
Article
in English
| MEDLINE | ID: mdl-20085491